bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: proficient rx lp
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler proficient rx lp
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 300 mg/1

Manufacturer
Proficient Rx LP

Identifiers & Regulatory

Product NDC 71205-465
Product ID 71205-465_293ee809-1b3d-4f31-9d46-ac413f126906
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210497
Listing Expiration 2026-12-31
Marketing Start 2019-03-25

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71205465
Hyphenated Format 71205-465

Supplemental Identifiers

RxCUI
993557
UPC
0371205465308
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA210497 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-30)
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-60)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-90)
source: ndc

Packages (3)

71205-465-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-30) 71205-465-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-60) 71205-465-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-90)

Ingredients (1)

bupropion hydrochloride (300 mg/1)

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "293ee809-1b3d-4f31-9d46-ac413f126906", "openfda": {"upc": ["0371205465308"], "unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["5d40e301-7e06-4ecd-b7c6-3d7ac6a134d2"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-30)", "package_ndc": "71205-465-30", "marketing_start_date": "20200729"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-60)", "package_ndc": "71205-465-60", "marketing_start_date": "20200729"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-90)", "package_ndc": "71205-465-90", "marketing_start_date": "20200729"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "71205-465_293ee809-1b3d-4f31-9d46-ac413f126906", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71205-465", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20190325", "listing_expiration_date": "20261231"}